A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers.

Name: A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers.
Published: 2002
License: Public Domain

University of Oxford · 2002

ClinicalTrials.gov · Datasets · License: Public Domain · 2002

Open Source ↗

immunogenicity mycobacteriumtuberculosis tuberculosis

tuberculosis, mycobacterium tuberculosis, 85a antigen, recombinant modified vaccinia virus ankara, phase i study, immunogenicity, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers.

Related documents